Athenagen Inc. Announces Name Change To CoMentis
2/20/2007 10:34:13 AM
More...
|
Athenagen Inc.'s Eye Drop Therapy For AMD Is Safe And Well Tolerated In Phase I Study
1/31/2007 10:50:54 AM
More...
|
Athenagen Inc. Initiates Phase II Clinical Trial In Alzheimer's Disease
12/13/2006 11:28:37 AM
More...
|
Athenagen Inc. Expands Leadership Team With Two Seasoned Drug Development Professionals
10/23/2006 11:22:37 AM
More...
|
Athenagen Inc. Raises $50 Million In Series B Financing
9/28/2006 8:46:09 AM
More...
|
The Day In Review: Amgen (AMGN) Gets Approval For Vectibix
9/27/2006 6:34:15 PM
More...
|
Athenagen Inc. Initiates Clinical Development Of Its Anti-Angiogenic Eye Drop Therapy For AMD
8/21/2006 9:23:37 AM
More...
|
Athenagen Inc. Completes Merger With Zapaq, Inc.
8/14/2006 10:19:54 AM
More...
|
Athenagen Inc. And Zapaq, Inc. To Merge
7/10/2006 12:01:27 PM
More...
|
Athenagen Inc. Advances Angiogenesis Drug To Clinical Testing
6/21/2006 10:41:42 AM
More...
|
|